Global Intravenous Immune Globulin Therapies Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 280417
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Intravenous Immune Globulin Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Intravenous Immune Globulin Therapies market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunodeficiency accounting for % of the Intravenous Immune Globulin Therapies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liquid Form segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Intravenous Immune Globulin Therapies include Baxter, Grifols, CSL Plasma, Octapharma, and Biotest, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Intravenous Immune Globulin Therapies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Liquid Form

Lyophilized Powder Form

Market segment by Application, can be divided into

Immunodeficiency

Autoimmune Disease

Acute Infection

Market segment by players, this report covers

Baxter

Grifols

CSL Plasma

Octapharma

Biotest

Kedrion

Kamada

China Biologic Products Holdings

Hualan Biological Engineering

Sichuan Yuanda Shuyang Pharmaceutical

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Intravenous Immune Globulin Therapies product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Intravenous Immune Globulin Therapies, with revenue, gross margin and global market share of Intravenous Immune Globulin Therapies from 2019 to 2022.

Chapter 3, the Intravenous Immune Globulin Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Intravenous Immune Globulin Therapies market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Intravenous Immune Globulin Therapies research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Intravenous Immune Globulin Therapies

1.2 Classification of Intravenous Immune Globulin Therapies by Type

1.2.1 Overview: Global Intravenous Immune Globulin Therapies Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Type in 2021

1.2.3 Liquid Form

1.2.4 Lyophilized Powder Form

1.3 Global Intravenous Immune Globulin Therapies Market by Application

1.3.1 Overview: Global Intravenous Immune Globulin Therapies Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Immunodeficiency

1.3.3 Autoimmune Disease

1.3.4 Acute Infection

1.4 Global Intravenous Immune Globulin Therapies Market Size & Forecast

1.5 Global Intravenous Immune Globulin Therapies Market Size and Forecast by Region

1.5.1 Global Intravenous Immune Globulin Therapies Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Intravenous Immune Globulin Therapies Market Size by Region, (2017-2022)

1.5.3 North America Intravenous Immune Globulin Therapies Market Size and Prospect (2017-2028)

1.5.4 Europe Intravenous Immune Globulin Therapies Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Intravenous Immune Globulin Therapies Market Size and Prospect (2017-2028)

1.5.6 South America Intravenous Immune Globulin Therapies Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Intravenous Immune Globulin Therapies Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Intravenous Immune Globulin Therapies Market Drivers

1.6.2 Intravenous Immune Globulin Therapies Market Restraints

1.6.3 Intravenous Immune Globulin Therapies Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Baxter

2.1.1 Baxter Details

2.1.2 Baxter Major Business

2.1.3 Baxter Intravenous Immune Globulin Therapies Product and Solutions

2.1.4 Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Baxter Recent Developments and Future Plans

2.2 Grifols

2.2.1 Grifols Details

2.2.2 Grifols Major Business

2.2.3 Grifols Intravenous Immune Globulin Therapies Product and Solutions

2.2.4 Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Grifols Recent Developments and Future Plans

2.3 CSL Plasma

2.3.1 CSL Plasma Details

2.3.2 CSL Plasma Major Business

2.3.3 CSL Plasma Intravenous Immune Globulin Therapies Product and Solutions

2.3.4 CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 CSL Plasma Recent Developments and Future Plans

2.4 Octapharma

2.4.1 Octapharma Details

2.4.2 Octapharma Major Business

2.4.3 Octapharma Intravenous Immune Globulin Therapies Product and Solutions

2.4.4 Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Octapharma Recent Developments and Future Plans

2.5 Biotest

2.5.1 Biotest Details

2.5.2 Biotest Major Business

2.5.3 Biotest Intravenous Immune Globulin Therapies Product and Solutions

2.5.4 Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Biotest Recent Developments and Future Plans

2.6 Kedrion

2.6.1 Kedrion Details

2.6.2 Kedrion Major Business

2.6.3 Kedrion Intravenous Immune Globulin Therapies Product and Solutions

2.6.4 Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Kedrion Recent Developments and Future Plans

2.7 Kamada

2.7.1 Kamada Details

2.7.2 Kamada Major Business

2.7.3 Kamada Intravenous Immune Globulin Therapies Product and Solutions

2.7.4 Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Kamada Recent Developments and Future Plans

2.8 China Biologic Products Holdings

2.8.1 China Biologic Products Holdings Details

2.8.2 China Biologic Products Holdings Major Business

2.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Product and Solutions

2.8.4 China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 China Biologic Products Holdings Recent Developments and Future Plans

2.9 Hualan Biological Engineering

2.9.1 Hualan Biological Engineering Details

2.9.2 Hualan Biological Engineering Major Business

2.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Product and Solutions

2.9.4 Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Hualan Biological Engineering Recent Developments and Future Plans

2.10 Sichuan Yuanda Shuyang Pharmaceutical

2.10.1 Sichuan Yuanda Shuyang Pharmaceutical Details

2.10.2 Sichuan Yuanda Shuyang Pharmaceutical Major Business

2.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product and Solutions

2.10.4 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Intravenous Immune Globulin Therapies Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Intravenous Immune Globulin Therapies Players Market Share in 2021

3.2.2 Top 10 Intravenous Immune Globulin Therapies Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Intravenous Immune Globulin Therapies Players Head Office, Products and Services Provided

3.4 Intravenous Immune Globulin Therapies Mergers & Acquisitions

3.5 Intravenous Immune Globulin Therapies New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Type (2017-2022)

4.2 Global Intravenous Immune Globulin Therapies Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2017-2022)

5.2 Global Intravenous Immune Globulin Therapies Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Intravenous Immune Globulin Therapies Revenue by Type (2017-2028)

6.2 North America Intravenous Immune Globulin Therapies Revenue by Application (2017-2028)

6.3 North America Intravenous Immune Globulin Therapies Market Size by Country

6.3.1 North America Intravenous Immune Globulin Therapies Revenue by Country (2017-2028)

6.3.2 United States Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

6.3.3 Canada Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

6.3.4 Mexico Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Intravenous Immune Globulin Therapies Revenue by Type (2017-2028)

7.2 Europe Intravenous Immune Globulin Therapies Revenue by Application (2017-2028)

7.3 Europe Intravenous Immune Globulin Therapies Market Size by Country

7.3.1 Europe Intravenous Immune Globulin Therapies Revenue by Country (2017-2028)

7.3.2 Germany Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

7.3.3 France Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

7.3.5 Russia Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

7.3.6 Italy Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Type (2017-2028)

8.2 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Application (2017-2028)

8.3 Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region

8.3.1 Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Region (2017-2028)

8.3.2 China Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

8.3.3 Japan Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

8.3.4 South Korea Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

8.3.5 India Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

8.3.7 Australia Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Intravenous Immune Globulin Therapies Revenue by Type (2017-2028)

9.2 South America Intravenous Immune Globulin Therapies Revenue by Application (2017-2028)

9.3 South America Intravenous Immune Globulin Therapies Market Size by Country

9.3.1 South America Intravenous Immune Globulin Therapies Revenue by Country (2017-2028)

9.3.2 Brazil Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

9.3.3 Argentina Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Type (2017-2028)

10.2 Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Application (2017-2028)

10.3 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country

10.3.1 Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Country (2017-2028)

10.3.2 Turkey Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

10.3.4 UAE Intravenous Immune Globulin Therapies Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Intravenous Immune Globulin Therapies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Intravenous Immune Globulin Therapies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Intravenous Immune Globulin Therapies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Intravenous Immune Globulin Therapies Revenue (USD Million) by Region (2017-2022)

Table 5. Global Intravenous Immune Globulin Therapies Revenue Market Share by Region (2023-2028)

Table 6. Baxter Corporate Information, Head Office, and Major Competitors

Table 7. Baxter Major Business

Table 8. Baxter Intravenous Immune Globulin Therapies Product and Solutions

Table 9. Baxter Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Grifols Corporate Information, Head Office, and Major Competitors

Table 11. Grifols Major Business

Table 12. Grifols Intravenous Immune Globulin Therapies Product and Solutions

Table 13. Grifols Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. CSL Plasma Corporate Information, Head Office, and Major Competitors

Table 15. CSL Plasma Major Business

Table 16. CSL Plasma Intravenous Immune Globulin Therapies Product and Solutions

Table 17. CSL Plasma Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Octapharma Corporate Information, Head Office, and Major Competitors

Table 19. Octapharma Major Business

Table 20. Octapharma Intravenous Immune Globulin Therapies Product and Solutions

Table 21. Octapharma Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Biotest Corporate Information, Head Office, and Major Competitors

Table 23. Biotest Major Business

Table 24. Biotest Intravenous Immune Globulin Therapies Product and Solutions

Table 25. Biotest Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Kedrion Corporate Information, Head Office, and Major Competitors

Table 27. Kedrion Major Business

Table 28. Kedrion Intravenous Immune Globulin Therapies Product and Solutions

Table 29. Kedrion Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Kamada Corporate Information, Head Office, and Major Competitors

Table 31. Kamada Major Business

Table 32. Kamada Intravenous Immune Globulin Therapies Product and Solutions

Table 33. Kamada Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. China Biologic Products Holdings Corporate Information, Head Office, and Major Competitors

Table 35. China Biologic Products Holdings Major Business

Table 36. China Biologic Products Holdings Intravenous Immune Globulin Therapies Product and Solutions

Table 37. China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Hualan Biological Engineering Corporate Information, Head Office, and Major Competitors

Table 39. Hualan Biological Engineering Major Business

Table 40. Hualan Biological Engineering Intravenous Immune Globulin Therapies Product and Solutions

Table 41. Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Sichuan Yuanda Shuyang Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 43. Sichuan Yuanda Shuyang Pharmaceutical Major Business

Table 44. Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product and Solutions

Table 45. Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Intravenous Immune Globulin Therapies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Intravenous Immune Globulin Therapies Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Intravenous Immune Globulin Therapies by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Intravenous Immune Globulin Therapies Players Head Office, Products and Services Provided

Table 50. Intravenous Immune Globulin Therapies Mergers & Acquisitions in the Past Five Years

Table 51. Intravenous Immune Globulin Therapies New Entrants and Expansion Plans

Table 52. Global Intravenous Immune Globulin Therapies Revenue (USD Million) by Type (2017-2022)

Table 53. Global Intravenous Immune Globulin Therapies Revenue Share by Type (2017-2022)

Table 54. Global Intravenous Immune Globulin Therapies Revenue Forecast by Type (2023-2028)

Table 55. Global Intravenous Immune Globulin Therapies Revenue by Application (2017-2022)

Table 56. Global Intravenous Immune Globulin Therapies Revenue Forecast by Application (2023-2028)

Table 57. North America Intravenous Immune Globulin Therapies Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Intravenous Immune Globulin Therapies Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Intravenous Immune Globulin Therapies Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Intravenous Immune Globulin Therapies Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Intravenous Immune Globulin Therapies Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Intravenous Immune Globulin Therapies Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Intravenous Immune Globulin Therapies Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Intravenous Immune Globulin Therapies Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Intravenous Immune Globulin Therapies Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Intravenous Immune Globulin Therapies Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Intravenous Immune Globulin Therapies Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Intravenous Immune Globulin Therapies Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Intravenous Immune Globulin Therapies Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Intravenous Immune Globulin Therapies Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Intravenous Immune Globulin Therapies Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Intravenous Immune Globulin Therapies Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Intravenous Immune Globulin Therapies Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Intravenous Immune Globulin Therapies Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Intravenous Immune Globulin Therapies Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Intravenous Immune Globulin Therapies Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Intravenous Immune Globulin Therapies Picture

Figure 2. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type in 2021

Figure 3. Liquid Form

Figure 4. Lyophilized Powder Form

Figure 5. Intravenous Immune Globulin Therapies Revenue Market Share by Application in 2021

Figure 6. Immunodeficiency Picture

Figure 7. Autoimmune Disease Picture

Figure 8. Acute Infection Picture

Figure 9. Global Intravenous Immune Globulin Therapies Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Intravenous Immune Globulin Therapies Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Intravenous Immune Globulin Therapies Revenue Market Share by Region (2017-2028)

Figure 12. Global Intravenous Immune Globulin Therapies Revenue Market Share by Region in 2021

Figure 13. North America Intravenous Immune Globulin Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Intravenous Immune Globulin Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Intravenous Immune Globulin Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Intravenous Immune Globulin Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Intravenous Immune Globulin Therapies Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Intravenous Immune Globulin Therapies Market Drivers

Figure 19. Intravenous Immune Globulin Therapies Market Restraints

Figure 20. Intravenous Immune Globulin Therapies Market Trends

Figure 21. Baxter Recent Developments and Future Plans

Figure 22. Grifols Recent Developments and Future Plans

Figure 23. CSL Plasma Recent Developments and Future Plans

Figure 24. Octapharma Recent Developments and Future Plans

Figure 25. Biotest Recent Developments and Future Plans

Figure 26. Kedrion Recent Developments and Future Plans

Figure 27. Kamada Recent Developments and Future Plans

Figure 28. China Biologic Products Holdings Recent Developments and Future Plans

Figure 29. Hualan Biological Engineering Recent Developments and Future Plans

Figure 30. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments and Future Plans

Figure 31. Global Intravenous Immune Globulin Therapies Revenue Share by Players in 2021

Figure 32. Intravenous Immune Globulin Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 33. Global Top 3 Players Intravenous Immune Globulin Therapies Revenue Market Share in 2021

Figure 34. Global Top 10 Players Intravenous Immune Globulin Therapies Revenue Market Share in 2021

Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 36. Global Intravenous Immune Globulin Therapies Revenue Share by Type in 2021

Figure 37. Global Intravenous Immune Globulin Therapies Market Share Forecast by Type (2023-2028)

Figure 38. Global Intravenous Immune Globulin Therapies Revenue Share by Application in 2021

Figure 39. Global Intravenous Immune Globulin Therapies Market Share Forecast by Application (2023-2028)

Figure 40. North America Intravenous Immune Globulin Therapies Sales Market Share by Type (2017-2028)

Figure 41. North America Intravenous Immune Globulin Therapies Sales Market Share by Application (2017-2028)

Figure 42. North America Intravenous Immune Globulin Therapies Revenue Market Share by Country (2017-2028)

Figure 43. United States Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Canada Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Mexico Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Europe Intravenous Immune Globulin Therapies Sales Market Share by Type (2017-2028)

Figure 47. Europe Intravenous Immune Globulin Therapies Sales Market Share by Application (2017-2028)

Figure 48. Europe Intravenous Immune Globulin Therapies Revenue Market Share by Country (2017-2028)

Figure 49. Germany Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific Intravenous Immune Globulin Therapies Sales Market Share by Type (2017-2028)

Figure 55. Asia-Pacific Intravenous Immune Globulin Therapies Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific Intravenous Immune Globulin Therapies Revenue Market Share by Region (2017-2028)

Figure 57. China Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South Korea Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Intravenous Immune Globulin Therapies Sales Market Share by Type (2017-2028)

Figure 64. South America Intravenous Immune Globulin Therapies Sales Market Share by Application (2017-2028)

Figure 65. South America Intravenous Immune Globulin Therapies Revenue Market Share by Country (2017-2028)

Figure 66. Brazil Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Argentina Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Middle East and Africa Intravenous Immune Globulin Therapies Sales Market Share by Type (2017-2028)

Figure 69. Middle East and Africa Intravenous Immune Globulin Therapies Sales Market Share by Application (2017-2028)

Figure 70. Middle East and Africa Intravenous Immune Globulin Therapies Revenue Market Share by Country (2017-2028)

Figure 71. Turkey Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Saudi Arabia Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. UAE Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Methodology

Figure 75. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz